SHPK
Sedoheptulokinase
Also known as: CARKL, SHK, SHPK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHJ6
- Gene
- SHPK
- Ensembl
- ENSG00000197417
- Chromosome
- 17
- Canonical length
- 478 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles
OverviewNCBI Gene
The protein encoded by this gene has weak homology to several carbohydrate kinases, a class of proteins involved in the phosphorylation of sugars as they enter a cell, inhibiting return across the cell membrane. Sequence variation between this novel gene and known carbohydrate kinases suggests the possibility of a different substrate, cofactor or changes in kinetic properties distinguishing it from other carbohydrate kinases. The gene resides in a region commonly deleted in cystinosis patients, suggesting a role as a modifier for the cystinosis phenotype. The genomic region is also rich in Alu repetitive sequences, frequently involved in chromosomal rearrangements. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
478 residues, UniProt reviewed canonical sequence.
>Q9UHJ6|SHPK
1 MAARPITLGI DLGTTSVKAA LLRAAPDDPS GFAVLASCAR AARAEAAVES AVAGPQGREQ
61 DVSRILQALH ECLAALPRPQ LRSVVGIGVS GQMHGVVFWK TGQGCEWTEG GITPVFEPRA
121 VSHLVTWQDG RCSSEFLASL PQPKSHLSVA TGFGCATIFW LLKYRPEFLK SYDAAGTIHD
181 YVVAMLCGLP RPLMSDQNAA SWGYFNTQSQ SWNVETLRSS GFPVHLLPDI AEPGSVAGRT
241 SHMWFEIPKG TQVGVALGDL QASVYSCMAQ RTDAVLNIST SVQLAASMPS GFQPAQTPDP
301 TAPVAYFPYF NRTYLGVAAS LNGGNVLATF VHMLVQWMAD LGLEVEESTV YSRMIQAAVQ
361 QRDTHLTITP TVLGERHLPD QLASVTRISS SDLSLGHVTR ALCRGIVQNL HSMLPIQQLQ
421 EWGVERVMGS GSALSRNDVL KQEVQRAFPL PMSFGQDVDA AVGAALVMLR RHLNQKESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SHPK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- liver: 23 nTPM
- duodenum: 13 nTPM
- small intestine: 11 nTPM
- pancreas: 11 nTPM
- adrenal gland: 9.5 nTPM
- kidney: 9.5 nTPM
Single-cell type
- goblet cells: 0.6 nCPM
- enteric stem cells: 0.5 nCPM
- enterocytes: 0.5 nCPM
- hofbauer cells: 0.5 nCPM
- cytotrophoblasts: 0.3 nCPM
- plasma cells: 0.3 nCPM
Immune cell
- NK-cell: 3.2 nTPM
- plasmacytoid DC: 3.2 nTPM
- myeloid DC: 3 nTPM
- naive CD4 T-cell: 3 nTPM
- eosinophil: 2.5 nTPM
- total PBMC: 2.5 nTPM
Brain region
- white matter: 23 nTPM
- basal ganglia: 16 nTPM
- cerebral cortex: 16 nTPM
- midbrain: 16 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SHPK.
Disease | AllUniProt
Conditions SHPK is implicated in, by any mechanism.
- Sedoheptulokinase deficiency (SHPKD) MIM:617213
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- cellular response to interleukin-13
- cellular response to interleukin-4
- cellular response to lipopolysaccharide
- pentose-phosphate shunt
- pentose-phosphate shunt, non-oxidative branch
- phosphorylation
- regulation of inflammatory response
- regulation of macrophage activation
Molecular functions
- ATP binding
- sedoheptulokinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SHPK as an antibody target. Whether an autoantibody or antibody against SHPK could matter depends on whether native SHPK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SHPK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SHPK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...